INVO Bioscience (INVO) Competitors $0.80 +0.05 (+6.68%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends INVO vs. PETV, PAVM, GCTK, BTCY, NURO, PSTV, CTCX, INBS, NUVO, and AEMDShould you be buying INVO Bioscience stock or one of its competitors? The main competitors of INVO Bioscience include PetVivo (PETV), PAVmed (PAVM), GlucoTrack (GCTK), Biotricity (BTCY), NeuroMetrix (NURO), Plus Therapeutics (PSTV), Carmell (CTCX), Intelligent Bio Solutions (INBS), Holdco Nuvo Group D.G (NUVO), and Aethlon Medical (AEMD). These companies are all part of the "surgical & medical instruments" industry. INVO Bioscience vs. PetVivo PAVmed GlucoTrack Biotricity NeuroMetrix Plus Therapeutics Carmell Intelligent Bio Solutions Holdco Nuvo Group D.G Aethlon Medical INVO Bioscience (NASDAQ:INVO) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership. Do analysts recommend INVO or PETV? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INVO Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/APetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community favor INVO or PETV? INVO Bioscience received 7 more outperform votes than PetVivo when rated by MarketBeat users. CompanyUnderperformOutperformINVO BioscienceOutperform Votes746.67% Underperform Votes853.33% PetVivoN/AN/A Which has more volatility & risk, INVO or PETV? INVO Bioscience has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 2.46, meaning that its share price is 146% more volatile than the S&P 500. Does the media refer more to INVO or PETV? In the previous week, INVO Bioscience had 1 more articles in the media than PetVivo. MarketBeat recorded 1 mentions for INVO Bioscience and 0 mentions for PetVivo. INVO Bioscience's average media sentiment score of 0.00 equaled PetVivo'saverage media sentiment score. Company Overall Sentiment INVO Bioscience Neutral PetVivo Neutral Is INVO or PETV more profitable? INVO Bioscience has a net margin of -122.79% compared to PetVivo's net margin of -1,036.82%. INVO Bioscience's return on equity of 0.00% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets INVO Bioscience-122.79% N/A -36.94% PetVivo -1,036.82%-1,038.50%-266.37% Do institutionals and insiders hold more shares of INVO or PETV? 12.0% of INVO Bioscience shares are held by institutional investors. Comparatively, 24.6% of PetVivo shares are held by institutional investors. 3.5% of INVO Bioscience shares are held by company insiders. Comparatively, 20.1% of PetVivo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has higher earnings and valuation, INVO or PETV? INVO Bioscience has higher revenue and earnings than PetVivo. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINVO Bioscience$5.77M0.53-$8.03MN/AN/APetVivo$970K11.55-$10.95M-$0.65-0.85 SummaryINVO Bioscience beats PetVivo on 7 of the 11 factors compared between the two stocks. Ad Porter & CompanyElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Get INVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INVO vs. The Competition Export to ExcelMetricINVO BioscienceSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.04M$4.45B$5.40B$8.53BDividend YieldN/A42.37%5.15%4.14%P/E RatioN/A37.84113.7615.14Price / Sales0.5364.751,483.0493.53Price / CashN/A49.2739.7134.04Price / Book-0.394.214.665.01Net Income-$8.03M$11.52M$119.06M$225.46M7 Day Performance-4.83%1.05%0.79%0.37%1 Month Performance18.05%0.94%5.65%3.57%1 Year Performance-38.62%39.40%36.80%29.42% INVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INVOINVO BioscienceN/A$0.80+6.7%N/A-33.5%$3.04M$5.77M0.0025Gap UpPETVPetVivoN/A$0.55+1.9%N/A-61.3%$11.21M$970,000.00-0.8520Gap UpHigh Trading VolumePAVMPAVmed4.1617 of 5 stars$1.03-3.7%$21.00+1,944.8%-73.0%$11.14M$2.45M-0.1390Positive NewsGCTKGlucoTrack0.8014 of 5 stars$1.74+3.6%N/A+98.9%$9.54MN/A-0.725Short Interest ↓Gap UpBTCYBiotricityN/A$0.41flatN/A-59.0%$9.27M$12.06M-0.2440Gap UpNURONeuroMetrix0.5528 of 5 stars$4.00-0.2%N/A+10.9%$8.12M$5.90M-0.7220Upcoming EarningsPSTVPlus Therapeutics2.7004 of 5 stars$1.35+3.1%$14.00+937.0%+4.7%$7.96M$4.91M-0.4320Upcoming EarningsCTCXCarmell1.0604 of 5 stars$0.33-3.0%N/A-83.8%$6.79M$12,320.000.0014Negative NewsINBSIntelligent Bio Solutions0.4422 of 5 stars$1.39+2.2%N/A-51.7%$5.91M$3.11M-0.0410News CoverageGap DownNUVOHoldco Nuvo Group D.GN/A$0.17-23.6%N/AN/A$5.65M$180,000.000.00N/AAEMDAethlon Medical2.7883 of 5 stars$0.38flat$7.00+1,720.0%-73.5%$5.36M$570,000.00-0.1010Analyst ForecastNews Coverage Related Companies and Tools Related Companies PetVivo Competitors PAVmed Competitors GlucoTrack Competitors Biotricity Competitors NeuroMetrix Competitors Plus Therapeutics Competitors Carmell Competitors Intelligent Bio Solutions Competitors Holdco Nuvo Group D.G Competitors Aethlon Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INVO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
